(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 9844.85 | 10323.91 | -4.64 | 28149.00 | 29173.25 | -3.51 | 39312.00 | 32384.37 | 21.39 |
| Other Income | 6.66 | -9.29 | -171.69 | 23.52 | 73.71 | -68.09 | 99.32 | 175.11 | -43.28 |
| PBIDT | 2475.50 | 2376.91 | 4.15 | 6144.31 | 6283.13 | -2.21 | 8481.71 | 6621.60 | 28.09 |
| Interest | 197.79 | 117.56 | 68.25 | 522.13 | 245.55 | 112.64 | 386.74 | 163.52 | 136.51 |
| PBDT | 2277.71 | 2259.35 | 0.81 | 5622.18 | 6037.58 | -6.88 | 8094.97 | 6458.08 | 25.35 |
| Depreciation | 361.59 | 383.21 | -5.64 | 1074.38 | 1077.88 | -0.32 | 1455.57 | 1261.61 | 15.37 |
| PBT | 1916.12 | 1876.14 | 2.13 | 4547.80 | 4959.70 | -8.30 | 6639.40 | 5196.47 | 27.77 |
| TAX | 489.07 | 478.14 | 2.29 | 1160.78 | 1224.74 | -5.22 | 1651.55 | 1331.31 | 24.05 |
| Deferred Tax | 34.50 | -23.78 | -245.08 | 81.89 | -62.85 | -230.29 | -50.51 | -3.76 | 1243.35 |
| PAT | 1427.05 | 1398.00 | 2.08 | 3387.02 | 3734.96 | -9.32 | 4987.85 | 3865.16 | 29.05 |
| Equity | 242.37 | 242.04 | 0.14 | 242.37 | 248.29 | -2.38 | 242.04 | 248.01 | -2.41 |
| PBIDTM(%) | 25.15 | 23.02 | 9.22 | 21.83 | 21.54 | 1.35 | 21.58 | 20.45 | 5.52 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1938.25 |
| Dr. Reddys Labs. | 1272.25 |
| Cipla | 1451.25 |
| Zydus Lifesciences | 1161.30 |
| Lupin | 2511.60 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: